What Should Insurers Include in an AI Governance Checklist in 2026?

The Direct Answer for Insurers

An AI governance checklist for insurers should cover purpose, data, model behavior, human oversight, regulatory classification, evidence, third parties, incident response, and retirement—not merely whether an algorithm is accurate. The minimum useful document is a register that identifies each AI system, its business owner, affected customers, decision rights, data sources, performance measures, and legal basis. It should also state whether the system merely recommends a decision or effectively makes it, because that distinction changes the level of control required. As of 23 September 2026, this is an operational priority rather than a technology preference: most provisions of the EU AI Act have applied since 2 August 2026, while additional rules for certain AI embedded in regulated products follow on 2 August 2027. U.S. insurance regulators are also increasing their expectations, although requirements vary by state and regulator. A sound checklist therefore connects governance activity to decisions the board, executives, and frontline managers can inspect. It is not a substitute for a formal AI policy, but it is the working control that turns policy into daily practice.

Also worth reading: Which AI Governance Tools Should Insurers Use in 2026? · How Can Insurers Optimize AI Governance Frameworks for Compliance and Efficiency in 2026? · What is an AI insurance agent governance framework and how do insurers implement it in 2026?

Why Insurance AI Needs a Stronger Governance Standard

Insurance decisions can affect access to cover, price, claims handling, and the financial support available during illness or loss. An inaccurate model may therefore create regulatory, conduct, reputational, and fairness exposure at the same time. A model that performs well in aggregate can still fail for particular occupations, ages, medical conditions, claims types, or geographic groups, so an average accuracy score is inadequate. Insurers also rely on data supplied by brokers, software vendors, aggregators, and model providers, which makes responsibility harder to assign than in a typical business application. The evidence problem is especially important for U.S. insurers serving European customers, where teams may need to demonstrate data quality, risk management, recordkeeping, and human oversight rather than rely on assurances from a vendor. A checklist makes those expectations visible. Its value is not that it certifies compliance; it is that it exposes unsupported assumptions before they become customer treatment or supervisory findings.

Regulatory Classification Should Be the First Test

The first question is not which algorithm the insurer purchased, but what the system does and what regulatory regime applies. Under the EU AI Act, prohibited-practice rules have applied since 2 February 2025, general-purpose AI obligations have applied since 2 August 2025, and most other provisions have applied since 2 August 2026. AI used for risk assessment or pricing in relation to natural persons in the areas of life and health insurance is treated as high-risk under the Act. Creditworthiness or credit-score evaluation for natural persons can also fall within the high-risk category, except where systems are used only for fraud detection or financial-risk purposes. Classification should be performed at both the system and use-case level: the same engine may be low-risk in one workflow and high-risk in another. Insurers should retain a written rationale, including relevant exclusions and responsible legal advice, rather than assuming every claim or underwriting tool has the same status.

The table is a control aid, not a legal safe harbor. Even a low-risk system can require governance if poor controls create conduct, privacy, security, or operational harm. Conversely, a high-risk label should trigger proportionate work rather than an indefinite program of documentation with no connection to production decisions.

Data, Testing, and the Evidence Spine

The checklist should require a data sheet for every material model, covering source, purpose, consent or lawful basis, quality, missingness, update frequency, and whether the dataset is fit for the decision being made. Testing should examine more than overall predictive performance: teams should measure error rates by protected or commercially relevant groups, test edge cases, compare results with existing processes, and assess whether proxy variables reproduce past discrimination. The threshold for escalation should be set before results are known; for example, a team might require human review if a 95% confidence interval shows a meaningful disparity or if a decision reverses more than 5% of manual cases. These figures are suggested controls rather than statutory limits. Evidence must be preserved in a form that a reviewer can reproduce, including dataset versions, feature definitions, validation reports, approval minutes, override reasons, and production-change records. A concise 'evidence spine' is more useful than a large collection of disconnected documents because it links each claim to a specific system version and decision date.

Validation should also include adversarial, security, and misuse testing. Generative systems can produce fabricated citations, invented policy terms, or instructions that cause a customer to take an inappropriate action. Underwriting and claims systems can be manipulated through inaccurate inputs, deliberately engineered claims, or repeated strategic probing. A control such as red-team testing before launch and after a major model update is therefore more informative than a once-a-year accuracy certificate. Sampling is still necessary, but an initial 5% or 10% review of flagged decisions may be too small for a high-volume workflow, while a 100% review is neither realistic nor always useful. Sampling rates should reflect risk, volume, and consequence, with rules for escalating the rate when a defect or complaint pattern appears. The checklist should state who can change the sample, who audits that choice, and when the review is repeated.

Human Oversight Must Be More Than a Named Approver

Human oversight fails when a reviewer lacks time, authority, information, or a meaningful route to challenge the model. The checklist should therefore define the reviewer's role, expected response time, available explanations, and documented grounds for overriding a recommendation. A useful design has at least two independent approval steps for major policy changes: one technical check and one business or compliance check. For individual adverse decisions, the customer-facing record should identify the actual decision-maker and preserve the reason for any override. Reviewers should receive training on the model's limits, relevant regulation, disability or bias awareness where appropriate, and the difference between checking a decision and simply confirming it. Systems should distinguish advisory, confirmation, and autonomous modes so that responsibility does not blur as automation increases. If the model consistently produces recommendations that reviewers accept automatically, that fact should trigger a reassessment rather than being treated as evidence that the process is mature.

A mature checklist measures whether intervention has any effect. It should report override rates, the outcomes of overrides, complaints, correction requests, and repeat errors by site or business unit. An override rate near zero may indicate high trust, poor challenge, or automation bias; only observation and record review can separate those explanations. Insurers should avoid designing a target override rate simply to meet a governance metric. Instead, the purpose is to identify where model performance, workflow design, or reviewer behavior has failed. These records also help when operational teams and corporate functions disagree, a common problem in projects that combine actuarial, underwriting, claims, IT, data, legal, and compliance expertise. The evidence problem identified in regulatory discussion is therefore partly an organizational issue: the correct evidence must reach the person authorized to act on it.

Third-Party AI, Agents, and Supply-Chain Controls

Contract language should be evaluated alongside technical controls. The checklist should identify the provider, subcontractors, hosting locations, model version, update process, data use, retention period, audit right, incident-notification period, and exit mechanism. A service-level agreement might require notice of a serious incident within 24 to 72 hours, a complete root-cause record within 10 business days, and advance notice of material model or data changes. Those periods should be calibrated to the insurer's reporting obligations, not copied mechanically. Contracts should also state that the insurer may inspect evidence needed for supervisory review and that the provider cannot silently replace a validated model with a different one. If customer data is processed outside the insurer's direct control, the contract should explain encryption, access logging, deletion, and incident cooperation. AI agents require particular attention because they may call tools, retrieve policy documents, initiate transactions, or escalate claims without a person interpreting every intermediate step. Tool permissions should therefore be limited by transaction value, customer impact, and data sensitivity.

Insurers should not treat procurement acceptance as validation. A vendor's benchmark may use data, labels, or thresholds that do not reflect the insurer's portfolio, and a change in the customer mix can invalidate a previously acceptable result. The checklist should require an internal acceptance test before deployment, a named party responsible for revalidation, and a right to suspend the service if monitoring is unavailable. A register of fourth-party dependencies is also useful when an agent relies on external data, payment, communications, or identity services. Regulators have warned that agents can increase conduct risk, particularly when they take actions that appear routine but alter customer treatment. Governance should ask what the agent is permitted to do autonomously, what actions require confirmation, and how the insurer reconstructs a disputed sequence after the fact. If those answers cannot be produced reliably, the autonomy level is probably too high.

Common Governance Mistakes and How to Avoid Them

One common mistake is building an inventory without connecting entries to accountable owners. A system list becomes a museum if nobody is responsible for monitoring, approving changes, or retiring the tool. Another is writing policies that say humans remain in control without measuring whether staff can actually intervene. A third is treating accuracy as the only performance measure, which ignores false positives, subgroup outcomes, drift, operational cost, and the effect of recommendations on customer treatment. Firms also confuse pilot activity with production control; a successful sandbox test says little about integrations, data changes, user behavior, and monitoring in live operations. Documentation is sometimes produced after a problem, when model versions and data snapshots can no longer be recovered.

The checklist should also address responsibility for legacy spreadsheets, rules engines, outsourced analytics, and internally built tools. Many consequential processes are described as 'not AI' even though they use machine learning, optimization, natural-language processing, or synthetic data. Classification should follow function and effect, not branding. Overdocumentation creates its own failure mode: hundreds of pages that executives do not read and reviewers cannot maintain. Controls should instead state the decision, threshold, evidence, owner, and escalation path in language that a frontline manager can use. Governance committees should periodically remove duplicative evidence and test whether the remaining records support a real decision. The strongest checklists evolve from production evidence and supervisory feedback rather than from template completion alone.

When to Act and What It May Cost

An insurer should act immediately when a system influences eligibility, price, claims, customer service, fraud detection, or regulatory reporting—especially if it uses personal data, generative AI, external vendors, or automated agents. New deployments should not go live until classification, ownership, testing, and monitoring are recorded. Existing systems should be prioritized using four factors: customer impact, reversibility, data sensitivity, and regulatory attention. A board or audit committee can reasonably request an inventory covering all systems within 90 days, a risk-based review of the highest-impact uses within 180 days, and a fuller operating program within 12 months. Those are management milestones, not legal deadlines. The 2 August 2026 application date for most EU AI Act provisions is a hard compliance point for relevant operations, while the 2 August 2027 date for certain product-embedded high-risk systems is a forward planning date.

There is no responsible universal price for an AI governance program because registry software, legal review, actuarial validation, control testing, and remediation have very different cost structures. A small insurer may begin with internal inventory work and periodic sampling, while a large carrier may fund a dedicated control function, monitoring platform, independent validation, and 24/7 incident process. Budgets should include more than model purchase or integration; they must cover data preparation, record retention, security, customer correction, training, external assurance, and eventual decommissioning. Cost is also driven by portfolio size and whether decisions are automated or advisory. The wrong economy is to save on monitoring and then pay for a model rebuild, mass claim reprocessing, customer remediation, or supervisory scrutiny. Governance is not free, but the relevant comparison is not software price against zero. It is controlled operating cost against the cost of unreliable decisions.

A Practical Governance Cadence

A workable cadence begins with an intake review before procurement or design, a documented classification decision, and an approval gate before release. During production, monitoring should cover data drift, outcome quality, subgroup performance, complaints, overrides, security events, and changes in human behavior. A quarterly review is sensible for high-impact systems, while lower-risk advisory tools might be reviewed annually and after material change. The frequency should rise when thresholds are breached, a vendor changes the model, regulation changes, or a new claim pattern appears. Records should be retained long enough to cover the insurer's legal, regulatory, contractual, and litigation needs; a 10-year retention rule may be appropriate for some underwriting and claims evidence, but it is not a universal statutory period. Each year, management should test a sample of systems from the register, trace decisions back to their evidence, and report remediation to the board or designated committee. The program should end with an exit plan for every material system, including data deletion and customer communication where relevant. That is what separates governance from procurement: it covers the full life of the technology, including the decision to stop using it.